Risk factors of retained products of conception after miscarriage or termination with gemeprost in the second trimester of pregnancy: a retrospective case-controlled study in Japanese population

被引:3
作者
Noguchi, Tomoko [1 ]
Shiro, Michihisa [1 ]
Nanjo, Sakiko [1 ]
Mizoguchi, Mika [1 ]
Ota, Nami [1 ]
Mabuchi, Yasushi [1 ]
Yagi, Shigetaka [1 ]
Minami, Sawako [1 ]
Ino, Kazuhiko [1 ]
机构
[1] Wakayama Med Univ, Dept Obstet & Gynecol, 811-1 Kimiidera, Wakayama 6410012, Japan
关键词
Retained products of conception; miscarriage; termination of pregnancy; ultrasonography; second trimester; MANAGEMENT; MORBIDITY; WOMEN;
D O I
10.1080/01443615.2021.1916810
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Retained products of conception (RPOC) is a complication that occurs in the second trimester of pregnancy. We enrolled 98 women who had a miscarriage or termination with gemeprost in the second trimester of pregnancy. Eighteen cases (18.4%) were RPOC-positive. The gestational week at miscarriage or termination was earlier in the RPOC-positive group than those in the RPOC-negative group (p = .003). The period of the third stage of labour was longer in the RPOC-positive group than in RPOC-negative group (p = .040). The proportion of placental forceps use was higher in the RPOC-positive group than in RPOC-negative group (p = .003). Multivariate logistic regression analysis showed that gestational week (OR: 3.53; p = .04) and use of placental forceps at delivery (OR: 2.21; p = .012) were independent risk factors for RPOC. Earlier gestational weeks at miscarriage or termination and use of placental forceps at delivery were predictive factors for RPOC after second trimester miscarriage or termination with gemeprost.Impact Statement What is already known on this subject? There have been some reports on risk factors of RPOC. A previous report showed that the termination of pregnancy with misoprostol at earlier periods was associated with an increased risk of RPOC. What the results of this study add? There have been few studies on the risk factors of RPOC after miscarriage or termination with gemeprost. In this study, we evaluated the risk factors of RPOC after miscarriage or termination of pregnancy with gemeprost in the second trimester. We found that an earlier gestational age (between 12 and 17 weeks) at delivery and using placental forceps to remove placenta were significant risk factors of RPOC after miscarriage or termination of pregnancy with gemeprost in the second trimester. What the implications are of these findings for clinical practice and/or further research? An earlier gestational age and using forceps to remove placenta may be significant risk factors for RPOC. The accurate evaluation and treatment for RPOC is important for maternal life-saving efforts and subsequent pregnancies. Further research is needed to draft a standardised protocol for RPOC.
引用
收藏
页码:501 / 504
页数:4
相关论文
共 16 条
  • [1] [Anonymous], 2004, RCOG GUIDELINE
  • [2] Operative hysteroscopy for retained products of conception: Efficacy and subsequent fertility
    Capmas, Perrine
    Lobersztajn, Anina
    Duminil, Laura
    Barral, Tiphaine
    Pourcelot, Anne-Gaelle
    Fernandez, Herve
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2019, 48 (03) : 151 - 154
  • [3] The use of power Doppler colour scoring to predict successful expectant management in women with an incomplete miscarriage
    Casikar, Ishwari
    Lu, Chuan
    Oates, Jennifer
    Bignardi, Tommaso
    Alhamdan, Dalya
    Condous, George
    [J]. HUMAN REPRODUCTION, 2012, 27 (03) : 669 - 675
  • [4] COMBS CA, 1991, OBSTET GYNECOL, V77, P863
  • [5] Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review
    Hooker, Angelo B.
    Aydin, Humeyra
    Brolmann, Hans A. M.
    Huirne, Judith A. F.
    [J]. FERTILITY AND STERILITY, 2016, 105 (01) : 156 - +
  • [6] Secondary postpartum haemorrhage: incidence, morbidity and current management
    Hoveyda, F
    MacKenzie, IZ
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2001, 108 (09): : 927 - 930
  • [7] Clinical and imaging predictors of management in retained products of conception
    Kamaya, Aya
    Krishnarao, Priya Menon
    Nayak, Nita
    Jeffrey, R. Brooke
    Maturen, Katherine E.
    [J]. ABDOMINAL RADIOLOGY, 2016, 41 (12) : 2429 - 2434
  • [8] Investigation of the freely available easy-to-use software 'EZR' for medical statistics
    Kanda, Y.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 (03) : 452 - 458
  • [9] Management of retained products of conception with marked vascularity
    Kitahara, Tomoko
    Sato, Yukiyasu
    Kakui, Kazuyo
    Tatsumi, Keiji
    Fujiwara, Hiroshi
    Konishi, Ikuo
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2011, 37 (05) : 458 - 464
  • [10] Immediate adverse events after second trimester medical termination of pregnancy: results of a nationwide registry study
    Mentula, Maarit J.
    Niinimaki, Maarit
    Suhonen, Satu
    Hemminki, Elina
    Gissler, Mika
    Heikinheimo, Oskari
    [J]. HUMAN REPRODUCTION, 2011, 26 (04) : 927 - 932